Concepedia

Publication | Open Access

Expression analysis of Akirin-2, NFκB-p65 and β-catenin proteins in imatinib resistance of chronic myeloid leukemia

DOIFull Paper Access

16

Citations

24

References

2018

Year

Arzu Zeynep Karabay, Tülin Özkan, Yalda Hekmatshoar, Buket Altınok Güneş, Asuman Sunguroğlu, Zeliha Büyükbingöl, Arzu Atalay, Fügen Aktan
Hematology

Abstract

We show for the first time that Akirin-2 can be a novel biomarker in imatinib resistance. Targeting Akirin-2, NFκB and β-catenin genes may provide an opportunity to overcome imatinib resistance in CML.

References

YearCitations

Page 1